Legend Biotech Corp Stock Price Patterns
| LEGN Stock | USD 17.50 0.22 1.24% |
Momentum 42
Sell Extended
Oversold | Overbought |
Using Legend Biotech hype-based prediction, you can estimate the value of Legend Biotech Corp from the perspective of Legend Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Legend Biotech to buy its stock at a price that has no basis in reality. In that case, they are not buying Legend because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Legend Biotech after-hype prediction price | USD 18.32 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Legend Biotech Basic Forecasting Models to cross-verify your projections. Legend Biotech After-Hype Price Density Analysis
As far as predicting the price of Legend Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Legend Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Legend Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Legend Biotech Estimiated After-Hype Price Volatility
In the context of predicting Legend Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Legend Biotech's historical news coverage. Legend Biotech's after-hype downside and upside margins for the prediction period are 15.02 and 21.62, respectively. We have considered Legend Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Legend Biotech is very steady at this time. Analysis and calculation of next after-hype price of Legend Biotech Corp is based on 3 months time horizon.
Legend Biotech Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Legend Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Legend Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Legend Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.90 | 3.30 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
17.50 | 18.32 | 3.39 |
|
Legend Biotech Hype Timeline
Legend Biotech Corp is now traded for 17.50. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Legend is forecasted to increase in value after the next headline, with the price projected to jump to 18.32 or above. The average volatility of media hype impact on the company the price is insignificant. The price boost on the next news is projected to be 3.39%, whereas the daily expected return is now at -0.9%. The volatility of related hype on Legend Biotech is about 0.0%, with the expected price after the next announcement by competition of 17.50. Legend Biotech Corp currently holds 350.6 M in liabilities with Debt to Equity (D/E) ratio of 0.29, which may suggest the company is not taking enough advantage from borrowing. Given the investment horizon of 90 days the next forecasted press release will be uncertain. Check out Legend Biotech Basic Forecasting Models to cross-verify your projections.Legend Biotech Related Hype Analysis
Having access to credible news sources related to Legend Biotech's direct competition is more important than ever and may enhance your ability to predict Legend Biotech's future price movements. Getting to know how Legend Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Legend Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| IRON | Disc Medicine | 0.00 | 0 per month | 0.00 | (0.05) | 4.33 | (4.35) | 14.87 | |
| ZLAB | Zai Lab | 0.00 | 0 per month | 0.00 | (0.28) | 4.56 | (4.03) | 10.32 | |
| AAPG | Ascentage Pharma Group | 0.00 | 0 per month | 0.00 | (0.14) | 5.25 | (6.36) | 16.72 | |
| TARS | Tarsus Pharmaceuticals | 0.00 | 0 per month | 0.00 | (0.05) | 3.78 | (3.76) | 12.48 | |
| ADPT | Adaptive Biotechnologies Corp | 0.00 | 0 per month | 3.94 | 0.03 | 9.94 | (4.95) | 29.55 | |
| SRRK | Scholar Rock Holding | 0.00 | 0 per month | 2.43 | 0.17 | 5.92 | (4.21) | 31.68 | |
| CELC | Celcuity LLC | 0.00 | 0 per month | 1.97 | 0.22 | 5.87 | (2.92) | 17.89 | |
| CGON | CG Oncology Common | 0.00 | 0 per month | 2.62 | 0.09 | 5.15 | (4.40) | 33.66 | |
| XENE | Xenon Pharmaceuticals | 0.00 | 0 per month | 1.96 | 0.0009 | 3.78 | (2.71) | 10.56 | |
| IDYA | Ideaya Biosciences | 0.00 | 0 per month | 2.09 | 0.03 | 4.27 | (3.68) | 10.56 |
Legend Biotech Additional Predictive Modules
Most predictive techniques to examine Legend price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Legend using various technical indicators. When you analyze Legend charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Legend Biotech Predictive Indicators
The successful prediction of Legend Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Legend Biotech Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Legend Biotech based on analysis of Legend Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Legend Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Legend Biotech's related companies.
Pair Trading with Legend Biotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Legend Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Legend Biotech will appreciate offsetting losses from the drop in the long position's value.Moving against Legend Stock
| 0.74 | BOLT | Bolt Biotherapeutics | PairCorr |
| 0.63 | ARWR | Arrowhead Pharmaceuticals | PairCorr |
| 0.62 | MRKR | Marker Therapeutics | PairCorr |
| 0.61 | CING | Cingulate | PairCorr |
| 0.49 | AEON | AEON Biopharma | PairCorr |
| 0.31 | SNSE | Sensei Biotherapeutics | PairCorr |
The ability to find closely correlated positions to Legend Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Legend Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Legend Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Legend Biotech Corp to buy it.
The correlation of Legend Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Legend Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Legend Biotech Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Legend Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Legend Biotech Basic Forecasting Models to cross-verify your projections. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Will Biotechnology sector continue expanding? Could Legend diversify its offerings? Factors like these will boost the valuation of Legend Biotech. Expected growth trajectory for Legend significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Legend Biotech data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Legend Biotech Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Legend Biotech's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Legend Biotech's market price to deviate significantly from intrinsic value.
Understanding that Legend Biotech's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Legend Biotech represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Legend Biotech's market price signifies the transaction level at which participants voluntarily complete trades.